Cancer Research UK logo.
SearchDonate
  • Search

A trial looking at apitolisib with everolimus for kidney cancer that has spread (ROVER)

Overview

Cancer types:

Kidney cancer, Renal cell cancer, Secondary cancers

Status:

Results

Phase:

Phase 2

Details

This trial compared apitolisib and everolimus for kidney cancer that had spread to another part of the body. It was for people with renal cell cancer (RCC).

The trial was open for people to join between 2011 and 2012. The team published the results in 2016.

Recruitment start: 1 October 2011

Recruitment end: 30 July 2012

How to join

Please note: In order to you will need to discuss it with your doctor, unless otherwise specified.

Chief investigators

Professor Thomas Powles

Supported by

Experimental Cancer Medicine Centre (ECMC)

NIHR Clinical Research Network: Cancer

Roche-Genentech

Last reviewed: 06 Jul 2023

CRUK internal database number: 8876

Help and support